Skip to main content

Stryker Corporation MedSurg and Neurotechnology (revenue)

  • SYK · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$309.64−0.88%Close 13 Nov 2026

MedSurg and Neurotechnology (revenue) at Stryker Corporation came to $3.7B for the quarter to 30 Sep 2026, up 9.2% from a year earlier.

As Stryker Corporation reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$3.1BMar 2025$3.3BJun 2025$3.4BSep 2025$4.0BDec 2025$3.2BMar 2026$3.6BJun 2026$3.7BSep 2026
Stryker Corporation MedSurg and Neurotechnology (revenue), every reported period
Period endingMedSurg and Neurotechnology (revenue)Change on a yearFiled
30 Sep 2026$3.7Bup 9.2%30 Oct 2026
30 Jun 2026$3.6Bup 9.7%26 Jun 2026
31 Mar 2026$3.2Bup 4.9%11 May 2026
31 Dec 2025$4.0B—11 Feb 2026
30 Sep 2025$3.4B—31 Oct 2025
30 Jun 2025$3.3B—1 Aug 2025
31 Mar 2025$3.1B—2 May 2025

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Stryker Corporation: Organic net sales (change on a year) · Neuro Cranial Instruments revenue · Orthopaedic Instruments revenue · Neuro Cranial - Interventional Spine revenue · Enabling Technologies revenue · Medical revenue · Endoscopy revenue · Trauma and Extremities revenue · Instruments revenue · Instruments (earlier basis) revenue · Ortho Tech revenue · Neuro Cranial revenue · Knees revenue · Vascular revenue · Hips revenue · Spinal Implants revenue · Orthopaedics (revenue) · United States revenue · Europe, Middle East, Africa revenue · Asia Pacific revenue · International revenue · financial statements

Every KPI and segment of SYK, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.